Cellectar Biosciences Jumps 200% After Geting Patent Identification Numbers For Cancer Targeting Drug Vehicles
May 20, 2016 at 13:09 PM EDT
Cellectar Biosciences, Inc. (NASDAQ: CLRB), an oncology-focused biotechnology company, revealed Friday that it got patent ...